Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2010
06/03/2010US20100136011 Antibodies that bind to obm
06/03/2010US20100135977 Compositions and methods for treating metabolic diseases
06/03/2010US20100135963 Use of pax4 in pancreatic cell proliferation
06/03/2010CA2748344A1 Enhanced bioactive formulations of resveratrol
06/03/2010CA2745004A1 Pyridine-3-carboxyamide derivative
06/03/2010CA2744828A1 Five crystal forms, methods of preparation, pharmaceutical compositions and applications of 3-(3'-carboxy-4'-hydroxy-anilino-carbo-)-6-nitro-7-hydroxy-8-methyl-coumarin)>>
06/03/2010CA2744817A1 Bile acid recycling inhibitors for treatment of obesity and diabetes
06/03/2010CA2744697A1 Use of compositions comprising bile acids, salts, and mimics thereof for treatment of obesity or diabetes
06/03/2010CA2744178A1 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
06/03/2010CA2743241A1 6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
06/02/2010EP2192120A1 Stable crystalline salt of 5-methyll-(6S)-tetrahydrofolic acid
06/02/2010EP2192113A1 Novel crystal form XI of atorvastatin hemi-calcium and processes for its preparation
06/02/2010EP2192112A1 Process for preparing atorvastatin hemi-calcium Form I
06/02/2010EP2191849A1 Drug for suppressing pathogen occurring<i>in vivo</i>
06/02/2010EP2191837A1 Blood sugar-modulating polypeptides
06/02/2010EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone
06/02/2010EP2191733A1 Nutrition containing fat blend
06/02/2010EP2190842A1 Polymorph forms of (s)-2-((4-benzofuranyl)carbonylaminomethyl)-1-((4-(2-methyl-5-(4-fluorophenyl)thiazolyl)carbonyl)piperidine
06/02/2010EP2190840A2 Chemical compounds 979
06/02/2010EP2190837A1 4-pyrimidinesulfamide derivative
06/02/2010EP2190820A2 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1
06/02/2010EP2190464A2 Use of leptin(22-56) as a therapeutic agent
06/02/2010EP2190463A2 Use of thymopentin as a therapeutic agent
06/02/2010EP2190459A1 Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent
06/02/2010EP2190456A2 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer
06/02/2010EP2190452A2 Use of a peptide as a therapeutic agent
06/02/2010EP2190450A2 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents
06/02/2010EP2190447A2 Use of stresscopin-related peptide as a therapeutic agent
06/02/2010EP2029601B1 Pyridopyrimidinone derivatives
06/02/2010EP1907386B1 Amino acid salts of rosiglitazone
06/02/2010EP1558571B1 Novel compounds useful in treating ppar mediated diseases
06/02/2010EP1553937B1 Glycinenitrile-based inhibitors of dipeptidyl peptidase iv
06/02/2010EP1541553B1 Indoline compound and medicinal use thereof
06/02/2010EP1483228B1 Nk1 antagonists
06/02/2010DE69224660C5 Mitteln zur modulierung von verfahren durch retinoid rezeptoren und dafür nützliche verbindungen Means for modulating process by retinoid receptors and for useful links
06/02/2010CN1973662B Chinese herbal medicine type green concentrated feed for raising fattening pig
06/02/2010CN1972698B Beta-hydroxy short to medium chain fatty acid polymer
06/02/2010CN1938042B Use of aromatic cation peptide in preparing medicine for relieving oxidative damage
06/02/2010CN1826336B Cyclohexanecarboxylic acid compound
06/02/2010CN1659180B Novel recombinant anticoagulant proteins
06/02/2010CN101720327A Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
06/02/2010CN101720319A Thiazolidine derivatives and methods for the preparation thereof
06/02/2010CN101717442A Polyethylene glycol recombination DesB30 human insulin, preparation method and application thereof
06/02/2010CN101717416A Derivative of alpha-amino phosphonic acid containing saccharide groups, preparation method and medical application thereof
06/02/2010CN101717410A Phosphorus-containing compounds & uses thereof
06/02/2010CN101717399A Compound with pyrazine and thiazolone structure and application thereof in preparing medicament for treating diabetes mellitus
06/02/2010CN101717345A Threonine chromium compound and preparation method thereof
06/02/2010CN101716347A Ruminant rumen-protected lysine and production method thereof
06/02/2010CN101716332A Use of phycocyanin for preventing and treating diabetes mellitus
06/02/2010CN101716302A Traditional Chinese medicine for treating diabetes mellitus
06/02/2010CN101716297A Weight-reducing health-care tea
06/02/2010CN101716294A Drop pill for treating diabetes mellitus
06/02/2010CN101716293A Traditional Chinese medicine combination for treating diabetes mellitus
06/02/2010CN101716290A Loach and finless eel fattening traditional Chinese medicine
06/02/2010CN101716283A Method for constructing dendrobium officinale polysaccharide fingerprinting
06/02/2010CN101716248A Traditional Chinese medicine composition for treating diabetes mellitus
06/02/2010CN101716241A Weight-losing and fat-lowering medicinal composition and preparation method thereof
06/02/2010CN101716229A Health-care tea for regulating blood sugar level and preparation method thereof
06/02/2010CN101716213A Traditional Chinese medicine effective fraction composition for detoxification and lipid lowering and preparation method thereof
06/02/2010CN101716206A Wild ginseng granules and preparation method thereof
06/02/2010CN101716196A Cordycepin extractive and application thereof in preparing hypoglycemic drugs or health-care foods
06/02/2010CN101716194A Multi-flavor chewable calcium tablets and production process thereof
06/02/2010CN101716188A Animal pancreatic extract for preventing and curing diabetes
06/02/2010CN101716182A combined medicine containing metformin hydrochloride and vitamin b12
06/02/2010CN101716181A Invert sugar medicament composition liposome injection and new application thereof
06/02/2010CN101716180A Combined medicament for supplementing zinc and calcium and preparation method thereof
06/02/2010CN101716166A Applications of 2', 4'-dihydroxyl-6'-methoxyl-3', 5'-dimethyl chalcone
06/02/2010CN101716165A Use of oxyresveratrol
06/02/2010CN101716154A Ursolic acid oral dispersant and preparation method thereof
06/02/2010CN101585757B Method for preparing curcumin, demethoxycurcumin and bisdemethoxycurcumin
06/02/2010CN101385718B Osmotic pump preparation composition for treating hyperlipemia
06/02/2010CN101306010B Function food for reducing the blood sugar and preventing diabetes complicating disease
06/02/2010CN101283982B Fenofibrate nanometer suspension and preparation method thereof
06/02/2010CN101264331B New purpose of Chinese medicine almond
06/02/2010CN101259278B Optimum matching multiple water-soluble vitamin medicinal composition containing high-efficiency bacteriostat and preparation thereof
06/02/2010CN101259261B Diabetes treating traditional Chinese medicine
06/02/2010CN101259101B Micrometre level arachidonic acid/docosahexaenoic acid emulsion and preparation thereof
06/02/2010CN101244057B 3-substituted oxygen group-3',4'-dimethoxy flavonoid compound with blood fat reducing function
06/02/2010CN101239046B Epalrestat dropping pills and preparation thereof
06/02/2010CN101234106B Use of imidazolone compounds for treating cardiovascular and cerebrovascular diseases
06/02/2010CN101230055B Lovastatin analogue as well as preparation method and uses thereof
06/02/2010CN101214263B Method for preparing freeze-dried powder containing bacillus natto and nattokinase
06/02/2010CN101204549B Composition of Chinese traditional medicine for diabetes mellitus
06/02/2010CN101199540B Polygonin sheet and preparing method thereof
06/02/2010CN101181545B Medicinal composition orally taken for treating diabetes
06/02/2010CN101053621B Traditional Chinese medicinal composition for treating obesity and its preparation method
06/02/2010CN101053592B Medicinal composition for treating impaired glucose tolerance and preparation method thereof
06/02/2010CN101036714B Medicinal composition for treating and/or preventing diabetes
06/02/2010CN101007771B Voglibose semi-hydrated crystal, its preparation method and its uses in medicament formulation
06/01/2010US7728033 Mycophenolate mofetil in diabetic nephropathy
06/01/2010US7728025 Glucokinase activators as antidiabetic, antiobesity agents; 5-(4-methanesulfonyl-phenoxy)-2-pyrazin-2-yl-6-(2-carbamoyl-phenoxy)-1H-benzimidazole for example
06/01/2010US7728016 Substituted 5-membered ring compounds and their use
06/01/2010US7727999 substituted 1,3,8-triaza-spiro[4.5]decan-2-one compounds, used as selective serotonin receptor antagonists, used rfor the treatment of schizophrenia, psychosis, headaches, hypertension, thrombosis, vasospasm, depression, anxiety, sleep disorders and appetite disorders
06/01/2010US7727998 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
06/01/2010US7727977 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes
06/01/2010US7727965 C-glycosylisoflavones having alkylaminoalkoxyl substituent, preparation and use of the same
06/01/2010US7727964 Peptides substituted with a functional group that reacts with an active site residue of the targeted protease, e.g., Cyclohexylglycine BoroAla, and compounds that can hydrolyzed to produce them; improved specificity for regulating glucose metabolism
06/01/2010CA2525867C Natural compounds and their derivatives for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
06/01/2010CA2515841C Novel 2-pyridine carboxamide derivatives
06/01/2010CA2457965C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives